Note: Conference materials, such as handouts and evaluations, are best viewed using Mozilla Firefox. If you do not have Firefox installed on your computer, please go to http://www.mozilla.com/en-US/firefox/ and follow the instructions to download the browser.

 

CPE Information

Conference Objectives

At the close of the HOPA's 8th Annual Conference, attendees will be better able to

1. describe current controversies relating to screening and treatment of patients with solid tumors and hematologic malignancies
2. summarize updates in the medical literature in relation to hematology/oncology
3. describe new and emerging therapies in hematology and oncology patients
4. understand recent developments in the medical literature regarding hematology/oncology medications.

Statement of Need/Program Overview

HOPA organizes an annual conference for hematology/oncology pharmacy practitioners to educate attendees about emerging research and new treatment regimens, provide clinical updates on treatment of tumor types and new supportive care therapies, and present an overview of common clinical and technical issues in the hematology/oncology clinical setting. The overall goal of educating oncology pharmacy practitioners about current developments is to improve the efficiency of healthcare delivery while maintaining or exceeding the quality of patient care. By informing hematology/oncology practitioners about the latest developments in clinical trials, therapeutic regimens, treatment guidelines, and emerging technologies, these individuals will be well positioned to participate in healthcare initiatives and clinical decision making that will have a direct and positive impact on cancer patient management. Objectives of the 2012 conference include educating attendees about topics of emerging interest in the management of cancer patients as well as practical issues that pharmacists face while delivering cancer care. Topics for HOPA's 8th Annual Conference, as well as scheduling, venue, and speakers, were chosen based on therapeutic advances in hematology/oncology, current medical news, input from HOPA's planning committees, and suggestions from last year's participants.

Hematology/Oncology Pharmacy Association Accreditation Statement

The Hematology/Oncology Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education

Credit Designation

The Hematology/Oncology Pharmacy Association designates this continuing education activity for a maximum of 31.25 contact hours (3.125 CEUs) of ACPE credits.

Disclosure of Conflicts of Interest

HOPA assesses conflict of interest with its faculty, planners, manager, and other individuals who are in a position to control the content of CPE activities. All potential conflicts of interest that are identified are thoroughly reviewed for fair balance, scientific objectivity of studies used in the activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CPE activities and related materials that promote improvements or quality in health care, and not specific proprietary commercial interests.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. HOPA and its faculty, planners, manager, and commercial supporters do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activities are those of the faculty and do not necessarily represent the views of HOPA or any other organizational or commercial entities.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

ACPE Credit

Attendees will be issued an audience response system (ARS) keycard at registration to record your responses to questions presented during the education sessions. HOPA may use this to validate your attendance for ACPE credit. To claim ACPE credit, complete the evaluations online through Conference Web Central at www.hoparx.org. Evaluate sessions online at the end of each day at the Cyber Cafe stations, which will be located in the registration area. Your CPE certificate may be created online, but do not print it until you have evaluated and claimed credit for all of the sessions you have attended at the conference. The six BCOP specialty sessions are open to all conference attendees for CPE credit. To help us assess your future educational needs, we ask that you complete this process by April 30, 2012; however, you will be able to claim credit for the meeting through December 31, 2012. After you have claimed credit, your certificate will remain available online and can be accessed at any time by logging onto your Credit Profile page at www.hopau.org.

CPE Monitor

If you have not yet set up your e-Profile with NABP, please click here to learn how to get your e-Profile number. Beginning in 2012, all pharmacists and pharmacy technicians will need to have this when they submit a request for CPE credit.

Board Certified Oncology Pharmacist (BCOP) Recertification Credit

You must attend all six BCOP specialty sessions to be eligible to take the posttest for six BCOP recertification credits. Please use your audience response system (ARS) keypad to register your attendance in each BCOP specialty session. If you did attend all six sessions, HOPA will e-mail a link to you by April 15, 2012, allowing you to purchase the posttest for $45. If you did not attend all six sessions at the HOPA conference, but you still want to earn BCOP recertification credit, the sessions will be repeated at the 2012 conferences of the American College of Clinical Pharmacy and the American Society of Health System Pharmacists. Please contact those organizations for details and schedules. You will have until December 31, 2012, to take the test. Notification of earned recertification credits will be sent to the Board of Pharmacy Specialties in early 2013. For more information, please visit here.